Novalis LifeSciences

What is Novalis LifeSciences?

Novalis LifeSciences is a boutique investment and advisory firm dedicated to the Life Science industry.

Founded in 2017 by Marijn E. Dekkers, the firm specializes in guiding and investing in visionary Life Science entrepreneurs.

Novalis LifeSciences operates as the direct investment vehicle and is part of a suite of companies that include Novalis Capital Partners LLC and Novalis Advisory LLC. They have assembled a team of experienced operating executives from the Life Science industry to provide nuanced insights and strategic guidance.

With $500 million in assets under management distributed across three venture capital funds, Novalis LifeSciences focuses on injecting capital into promising companies within three main areas: life science tools, molecular diagnostics, and biopharma therapeutics.

Their portfolio includes notable companies such as Cerevel Therapeutics, Quanterix, Decipher Biosciences, Ginkgo Bioworks, and Allurion Technologies, many of which have achieved significant milestones including public listings or acquisitions. The firm demonstrates its commitment to the advancement of the Life Science industry by not only providing financial investments but also serving as a strategic advisor through Novalis Advisory LLC.

Their influence and investment extend to various innovative efforts in the field, including the development of novel RNA editing therapeutics, acceleration of cell therapy manufacturing, advancement of medical AI development, and improvement of early cancer detection technologies.